Optimization of cancer immunotherapy through pyroptosis: A pyroptosis-related signature predicts survival benefit and potential synergy for immunotherapy in glioma.
Zeng Y, Cai Y, Chai P, Mao Y, Chen Y, Wang L, Zeng K, Zhan Z, Xie Y, Li C, Zhan H, Zhao L, Chen X, Zhu X, Liu Y, Chen M, Song Y, Zhou A.
Zeng Y, et al. Among authors: cai y.
Front Immunol. 2022 Aug 3;13:961933. doi: 10.3389/fimmu.2022.961933. eCollection 2022.
Front Immunol. 2022.
PMID: 35990696
Free PMC article.